FDA inspection
Livzon New North River Pharmaceutical Co., Ltd.: FDA inspection ending May 23, 2019
FDA inspection 1095580 · No Action Indicated (NAI) · Qingyuan
Key facts
| Inspection ID | 1095580 |
|---|---|
| Firm | Livzon New North River Pharmaceutical Co., Ltd. |
| FEI number | 3005619530 |
| Address | Ren Min Second Road |
| City | Qingyuan |
| Country | China |
| Fiscal year | 2019 |
| Inspection end date | May 23, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data